Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
6.95
-0.02 (-0.29%)
Jul 4, 2025, 2:45 PM CST

Jinling Pharmaceutical Company Company Description

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products and medical devices in China.

The company provides Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, polyarteritis, acute arterial embolism of extremities, diabetic gangrene, intravenous thrombus, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; lentinan injection for the treatment of malignant tumors; and absorbable gelatin sponges for the treatment of wound hemostasis.

It also offers medical and health care services. Jinling Pharmaceutical Company Limited was founded in 1998 and is headquartered in Nanjing, China.

Jinling Pharmaceutical Company Limited
Country China
Founded 1998
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,789
CEO Hai Chen

Contact Details

Address:
Jinling Pharmaceutical Building
Nanjing, 210009
China
Phone 86 25 8311 8511
Website jlyy1999.com

Stock Details

Ticker Symbol 000919
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE0000010W5
SIC Code 2834

Key Executives

Name Position
Hai Chen President and Director
Yang Wang Vice President, Chief Accountant, Secretary and Non-Independent Director
Quan Li Chief Economist
Mingyi Jia Chief Engineer
Jian Wang Executive Vice President and Non-Independent Director
Jian Li Vice President
Xinning Zhu Assistant to President
Zhenxin Xi General Manager Assistant
Xin Liu Assistant to the President
Mingyi Jia Chief Engineer